Our Story

At Plasfer, we pioneer the next generation cell therapies for the treatment of human diseases. Built on the innovative discoveries of Professor Paolo Gresele and Dr. Marco Malvestiti at the Department of Medicine of the University of Perugia, our groundbreaking approach in manipulating and engineering of human platelets has generated an entirely novel class of platelet-based cell therapies.

Leadership

MARCO MALVESTITI

Marco Malvestiti

President and CEO

President and Chief Executive Officer

Rosario Billetta CSO Plasfer

Rosario Billetta

COO

Chief Operating Officer

Paolo Gresele

CSO

Chief Scientific Officer

Luigi De Marco

CTO

Chief Technology Officer

ALESSANDRO CAPRAI

Alessandro Caprai

VP Marketing

VP Marketing and IT

Board of Directors

MARCO MALVESTITI

Marco Malvestiti

CEO and Director

Paolo Gresele

CSO and Director

Luigi De Marco

CTO and Director

Giacomo Rimatori

Corporate Counsel and Director

Headquarter

Plasfer, founded in 2015, is a pre-clinical stage biopharmaceutical company, located in Perugia, Umbria (Italy). The region of Umbria is located in the hearth of Italy, and it is renowned for its high quality of life.  Still Umbria is strategically located and at a distance of only 150km from Rome and Florence.

.

R&D Operations

Plasfer has access to a dedicated and fully equipped laboratory and administrative facilities as well as a state-of-the-art animal facility through a “spin-off” agreement with the Department of Medicine at the University of Perugia, Italy.

Menu